KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 126 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q4 2022. The put-call ratio across all filers is 0.49 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $3,158,060 | -34.9% | 293,500 | -9.3% | 0.02% | -42.4% |
| Q4 2022 | $4,849,581 | +19.0% | 323,737 | +2.0% | 0.03% | +3.1% |
| Q3 2022 | $4,076,000 | +520.4% | 317,446 | +572.9% | 0.03% | +700.0% |
| Q2 2021 | $657,000 | -29.7% | 47,178 | -6.6% | 0.00% | -42.9% |
| Q1 2021 | $935,000 | +34.3% | 50,513 | +28.2% | 0.01% | +16.7% |
| Q4 2020 | $696,000 | +8.8% | 39,394 | -5.7% | 0.01% | -14.3% |
| Q3 2020 | $640,000 | -44.4% | 41,780 | -7.5% | 0.01% | -41.7% |
| Q2 2020 | $1,151,000 | +50.1% | 45,157 | -8.8% | 0.01% | +20.0% |
| Q1 2020 | $767,000 | +20.4% | 49,524 | -14.1% | 0.01% | +66.7% |
| Q4 2019 | $637,000 | – | 57,627 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Spearhead Capital Advisors, LLC | 202,580 | $2,601,000 | 2.82% |
| Lion Point Capital, LP | 480,000 | $5,140,000 | 1.13% |
| HHLR ADVISORS, LTD. | 2,920,023 | $37,493,000 | 0.99% |
| TANG CAPITAL MANAGEMENT LLC | 600,000 | $7,704,000 | 0.94% |
| Rubric Capital Management LP | 1,446,107 | $18,568,000 | 0.94% |
| AlphaCentric Advisors LLC | 43,000 | $552,000 | 0.57% |
| RICE HALL JAMES & ASSOCIATES, LLC | 749,933 | $9,629,000 | 0.56% |
| Parkman Healthcare Partners LLC | 126,192 | $1,620,000 | 0.46% |
| Birchview Capital, LP | 30,000 | $385,000 | 0.27% |
| Baker Brothers Advisors | 2,799,577 | $35,947,000 | 0.24% |